RxDoctor Payments Data

Logan Higbee, PA

Medical · Pocatello, IDNPI 1992019202

Payments from drug & device makers

$555in general payments, 2019–2025

Across 29 payments — averaging $19.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$311
  • Pfizer$63
  • Biohaven Pharmaceuticals, Inc.$27
  • Abbott$23
  • Nestle Healthcare Nutrition Inc.$21
  • Novo Nordisk$19
  • plus $91 from 6 others

What the payments were for

  • Food & beverage$555100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$555 in reported general payments places this provider in the 55th percentile of 265 medical providers in Idaho.

See all medical providers in Idaho

Medicare billing

Part B allowed, 2024
$340
Medicare patients
29
Services billed
56

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide61$62,309
FarxigaDapagliflozin Propanediol90$51,755
TrulicityDulaglutide27$27,205
RybelsusSemaglutide23$26,647
JanuviaSitagliptin Phosphate20$18,419
JardianceEmpagliflozin20$15,394
JanumetSitagliptin Phos/Metformin Hcl26$14,340
XareltoRivaroxaban18$13,633
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$10,194
Spiriva RespimatTiotropium Bromide17$8,588
Stiolto RespimatTiotropium Br/Olodaterol Hcl16$7,313
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl13$4,992
Lantus SolostarInsulin Glargine,hum.Rec.Anlog33$3,588
Varenicline Tartrate14$1,813
Atorvastatin Calcium256$1,762

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$19$88,95684 claims
AstraZenecaFarxiga$17$51,75590 claims
Lilly USA, LLCTrulicity$16$27,20527 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 265 medical providers in Idaho.

Other medical in Pocatello

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →